157823-76-2

Usage

Uses

Used in Pharmaceutical Industry:
(S)-METHYL 3-BENZYL-2-OXOOXAZOLIDINE-4-CARBOXYLATE is used as a building block for the synthesis of various pharmaceuticals and bioactive compounds. Its unique structure and chirality make it a valuable component in the development of new drugs and therapeutic agents.
Used in Organic Synthesis:
In the field of organic synthesis, (S)-METHYL 3-BENZYL-2-OXOOXAZOLIDINE-4-CARBOXYLATE is used as a key intermediate for the creation of complex organic molecules. Its versatility allows for its incorporation into a wide range of chemical reactions and the formation of diverse molecular structures.
Used in Medicinal Chemistry:
(S)-METHYL 3-BENZYL-2-OXOOXAZOLIDINE-4-CARBOXYLATE is utilized as a chiral building block in medicinal chemistry, contributing to the development of enantiomerically pure compounds with potential therapeutic applications. Its presence in the synthesis of pharmaceutical intermediates highlights its importance in drug discovery and design.
Used in Drug Development:
With its potential applications in medicinal chemistry, (S)-METHYL 3-BENZYL-2-OXOOXAZOLIDINE-4-CARBOXYLATE plays a role in drug development. It aids researchers in the synthesis and optimization of new drug candidates, ultimately contributing to the advancement of novel therapeutic agents for various medical conditions.

InChI:InChI=1/C12H13NO4/c1-16-11(14)10-8-17-12(15)13(10)7-9-5-3-2-4-6-9/h2-6,10H,7-8H2,1H3/t10-/m0/s1

Upstream product

• 157823-75-1 (R)-3-benzyl-4-(hydroxymethyl)oxazolidin-2-one 
• 3173-56-6 benzyl isothiocyanate 
• 186581-53-3 diazomethane 
• 867344-14-7 (S)-3-Benzyl-2-oxo-oxazolidine-4-carboxylic acid 

Downstream Products

• 157823-78-4 (S)-4-Benzoyl-3-benzyl-oxazolidin-2-one 
• 837375-14-1 (S)-3-Benzyl-4-[(R)-4-(tert-butyl-dimethyl-silanyloxy)-1-hydroxy-but-2-ynyl]-oxazolidin-2-one 
• 874918-14-6 (4S)-3-benzyl-4-[4'-(tetrahydro-pyran-2'-yloxy)-but-2'-ynoyl]-oxazolidin-2-one 
• 157823-80-8 (S)-3-Benzyl-4-((S)-hydroxy-phenyl-methyl)-oxazolidin-2-one 
• 157823-83-1 (S)-3-Benzyl-4-((R)-hydroxy-phenyl-methyl)-oxazolidin-2-one 
• 157823-82-0 (S)-3-Benzyl-4-((R)-1-hydroxy-ethyl)-oxazolidin-2-one 
• 157823-79-5 (S)-3-Benzyl-4-((S)-1-hydroxy-ethyl)-oxazolidin-2-one 
• 157823-81-9 Benzoic acid (R)-1-((S)-3-benzyl-2-oxo-oxazolidin-4-yl)-ethyl ester 
• 68534-64-5 (1S,2S)-(+)-2-(benzylamino)-1-phenylpropane-1,3-diol 
• 724702-24-3 (S)-3-benzyl-4-((R,E)-1-hydroxyhexadec-2-enyl)oxazolidin-2-one 
• 837375-13-0 3-benzyl-4-[4-(tert-butyl-dimethyl-silanyloxy)-but-2-ynoyl]-oxazolidin-2-one 
• 544476-91-7 (S)-3-Benzyl-4-[12-(tetrahydro-pyran-2-yloxy)-dodec-2-ynoyl]-oxazolidin-2-one 
• 157823-77-3 (S)-4-Acetyl-3-benzyl-oxazolidin-2-one 

Relevant academic research and scientific papers

Diastereoselective Synthesis of γ-Hydroxy-β-amino Alcohols, (2S,3S)- and (2S,3R)-Threoninol and -Hydroxyphenylalaninol, from (R)-Glycidol via the Derived 4-Hydroxymethyloxazolidinone

Syntheses of enantiomerically pure (2S,3S)- and (2S,3R)-threoninol and (2S,3R)-hydroxyphenylalaninol are demonstrated starting from (R)-glycidol via (S)-4-methoxycarbonyl-2-oxazolidinone by monoalkylation of the ester followed by diastereoselective reduct